Imaxio

Chemicals & Related Products · France · 11-50 Employees

View Company Info for Free

Overview

Headquarters

99 Rue De Gerland, Lyon, Auvergne-Rhone-...

Revenue

$5.5 Million

Industry

Chemicals & Related Products Manufacturing Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Imaxio

IMAXIO is an integrated biotech company focused on immunology. It owns a pipeline of vaccines composed marketed, clinical-stage and preclinical-stage products: Marketed pharmaceuticals: a vaccine against human leptospirosis marketed in France. R&D pipeline based on the IMX313 technology platform: two clinical-stage projects and several preclinical-stage candidates, based on an antigen re-engineering platform to improve their immunogenicity, to develop more effective vaccines & immunotherapies. IMAXIO's main objective is to develop its R&D projects up to phase I / phase II clinical trials, and then out-licensed them to biopharmaceutical companies for phase III development and commercialization. IMAXIO remains open to new collaborations, for partners who are seeking technologies to improve the immune response on otherwise poorly immunogenic antigens. IMAXIO was created in 2000 as a spin-off of the Medical Research Council and the University of Cambridge (United-Kingdom).Explore more
Imaxio's Social MediaPopular SearchesImaxio SAImaxioImaxio CoSIC Code 28,283NAICS Code 32,325Show more

Is Imaxio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Imaxio is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Imaxio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Imaxio.

Imaxio financials insights

Gather financial insights about Imaxio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2012

Unspecified

$4M

2013

Grant

$7.2M

2014

Grant

$772K

See All Imaxio's Financials Insights

Imaxio Tech Stack

A closer look at the technologies used by Imaxio

Top Chemicals & Related Products Companies

Frequently Asked Questions Regarding Imaxio

What is Imaxio's official website?
Imaxio's official website is www.imaxio.com
What is Imaxio's Revenue?
Imaxio's revenue is $5.5 Million
What is Imaxio's SIC code?
Imaxio's SIC: 28,283
What is Imaxio's NAICS code?
Imaxio's NAICS: 32,325
How many employees does Imaxio have?
Imaxio has 11-50 employees
What industry does Imaxio belong to?
Imaxio is in the industry of: Chemicals & Related Products, Manufacturing, Business Services
What technology does Imaxio use?
Some of the popular technologies that Imaxio uses are: WordPress.org, reCAPTCHA, PHP, Snowplow
What does Imaxio do?

IMAXIO is an integrated biotech company focused on immunology. It owns a pipeline of vaccines composed marketed, clinical-stage and preclinical-stage products: Marketed pharmaceuticals: a vaccine against human leptospirosis marketed in France. R&D pipeline based on the IMX313 technology platform: two clinical-stage projects and several preclinical-... stage candidates, based on an antigen re-engineering platform to improve their immunogenicity, to develop more effective vaccines & immunotherapies. IMAXIO's main objective is to develop its R&D projects up to phase I / phase II clinical trials, and then out-licensed them to biopharmaceutical companies for phase III development and commercialization. IMAXIO remains open to new collaborations, for partners who are seeking technologies to improve the immune response on otherwise poorly immunogenic antigens. IMAXIO was created in 2000 as a spin-off of the Medical Research Council and the University of Cambridge (United-Kingdom).Read More

What are Imaxio social media links?
Imaxio Linkedin page Imaxio Twitter page
Who invested in Imaxio?
Imaxio has 3 investors including Agence nationale de la recherche ANR and Jenner Institute.
Is Imaxio a public company?
Imaxio is private company therefore does not currently have an official ticker symbol
See more information about Imaxio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.